257 related articles for article (PubMed ID: 21469116)
1. Killing of myeloid APCs via HLA class I, CD2 and CD226 defines a novel mechanism of suppression by human Tr1 cells.
Magnani CF; Alberigo G; Bacchetta R; Serafini G; Andreani M; Roncarolo MG; Gregori S
Eur J Immunol; 2011 Jun; 41(6):1652-62. PubMed ID: 21469116
[TBL] [Abstract][Full Text] [Related]
2. Consequences of double negative regulatory T cell and antigen presenting cell interaction on immune response suppression.
Ford McIntyre MS; Gao JF; Li X; Naeini BM; Zhang L
Int Immunopharmacol; 2011 May; 11(5):597-603. PubMed ID: 21109036
[TBL] [Abstract][Full Text] [Related]
3. Granulysin- and granzyme-dependent elimination of myeloid cells by therapeutic ova-specific type 1 regulatory T cells.
Guipouy D; Gertner-Dardenne J; Pfajfer L; German Y; Belmonte N; Dupré L
Int Immunol; 2019 Mar; 31(4):239-250. PubMed ID: 30778577
[TBL] [Abstract][Full Text] [Related]
4. Role of human leukocyte antigen-G in the induction of adaptive type 1 regulatory T cells.
Gregori S; Magnani CF; Roncarolo MG
Hum Immunol; 2009 Dec; 70(12):966-9. PubMed ID: 19664675
[TBL] [Abstract][Full Text] [Related]
5. Primary Tr1 cells from metastatic melanoma eliminate tumor-promoting macrophages through granzyme B- and perforin-dependent mechanisms.
Yan H; Zhang P; Kong X; Hou X; Zhao L; Li T; Yuan X; Fu H
Tumour Biol; 2017 Apr; 39(4):1010428317697554. PubMed ID: 28378637
[TBL] [Abstract][Full Text] [Related]
6. Differentiation and Characterization of Tr1 Cells.
Chihara N; Madi A; Karwacz K; Awasthi A; Kuchroo VK
Curr Protoc Immunol; 2016 Apr; 113():3.27.1-3.27.10. PubMed ID: 27038462
[TBL] [Abstract][Full Text] [Related]
7. Engineered T Regulatory Type 1 Cells for Clinical Application.
Gregori S; Roncarolo MG
Front Immunol; 2018; 9():233. PubMed ID: 29497421
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10-dependent ILT4/HLA-G pathway.
Gregori S; Tomasoni D; Pacciani V; Scirpoli M; Battaglia M; Magnani CF; Hauben E; Roncarolo MG
Blood; 2010 Aug; 116(6):935-44. PubMed ID: 20448110
[TBL] [Abstract][Full Text] [Related]
9. CD55 costimulation induces differentiation of a discrete T regulatory type 1 cell population with a stable phenotype.
Sutavani RV; Bradley RG; Ramage JM; Jackson AM; Durrant LG; Spendlove I
J Immunol; 2013 Dec; 191(12):5895-903. PubMed ID: 24198281
[TBL] [Abstract][Full Text] [Related]
10. Human CD25+CD4+ T suppressor cell clones produce transforming growth factor beta, but not interleukin 10, and are distinct from type 1 T regulatory cells.
Levings MK; Sangregorio R; Sartirana C; Moschin AL; Battaglia M; Orban PC; Roncarolo MG
J Exp Med; 2002 Nov; 196(10):1335-46. PubMed ID: 12438424
[TBL] [Abstract][Full Text] [Related]
11. Dysfunction of IL-10-producing type 1 regulatory T cells and CD4(+)CD25(+) regulatory T cells in a mimic model of human multiple sclerosis in Cynomolgus monkeys.
Ma A; Xiong Z; Hu Y; Qi S; Song L; Dun H; Zhang L; Lou D; Yang P; Zhao Z; Wang X; Zhang D; Daloze P; Chen H
Int Immunopharmacol; 2009 May; 9(5):599-608. PubMed ID: 19539557
[TBL] [Abstract][Full Text] [Related]
12. Eomesodermin controls a unique differentiation program in human IL-10 and IFN-γ coproducing regulatory T cells.
Gruarin P; Maglie S; De Simone M; Häringer B; Vasco C; Ranzani V; Bosotti R; Noddings JS; Larghi P; Facciotti F; Sarnicola ML; Martinovic M; Crosti M; Moro M; Rossi RL; Bernardo ME; Caprioli F; Locatelli F; Rossetti G; Abrignani S; Pagani M; Geginat J
Eur J Immunol; 2019 Jan; 49(1):96-111. PubMed ID: 30431161
[TBL] [Abstract][Full Text] [Related]
13. IL-10-Engineered Human CD4
Locafaro G; Andolfi G; Russo F; Cesana L; Spinelli A; Camisa B; Ciceri F; Lombardo A; Bondanza A; Roncarolo MG; Gregori S
Mol Ther; 2017 Oct; 25(10):2254-2269. PubMed ID: 28807569
[TBL] [Abstract][Full Text] [Related]
14. Adenosine and prostaglandin E2 cooperate in the suppression of immune responses mediated by adaptive regulatory T cells.
Mandapathil M; Szczepanski MJ; Szajnik M; Ren J; Jackson EK; Johnson JT; Gorelik E; Lang S; Whiteside TL
J Biol Chem; 2010 Sep; 285(36):27571-80. PubMed ID: 20558731
[TBL] [Abstract][Full Text] [Related]
15. IFN-alpha and IL-10 induce the differentiation of human type 1 T regulatory cells.
Levings MK; Sangregorio R; Galbiati F; Squadrone S; de Waal Malefyt R; Roncarolo MG
J Immunol; 2001 May; 166(9):5530-9. PubMed ID: 11313392
[TBL] [Abstract][Full Text] [Related]
16. Generation of highly suppressive adaptive CD8(+)CD25(+)FOXP3(+) regulatory T cells by continuous antigen stimulation.
Mahic M; Henjum K; Yaqub S; Bjørnbeth BA; Torgersen KM; Taskén K; Aandahl EM
Eur J Immunol; 2008 Mar; 38(3):640-6. PubMed ID: 18266270
[TBL] [Abstract][Full Text] [Related]
17. Cutting edge: induction of B7-H4 on APCs through IL-10: novel suppressive mode for regulatory T cells.
Kryczek I; Wei S; Zou L; Zhu G; Mottram P; Xu H; Chen L; Zou W
J Immunol; 2006 Jul; 177(1):40-4. PubMed ID: 16785496
[TBL] [Abstract][Full Text] [Related]
18. Different roles of the CD2 and LFA-1 T-cell co-receptors for regulating cytotoxic, proliferative, and cytokine responses of human V gamma 9/V delta 2 T cells.
Wang P; Malkovsky M
Mol Med; 2000 Mar; 6(3):196-207. PubMed ID: 10965495
[TBL] [Abstract][Full Text] [Related]
19. Type I regulatory T cells specific for desmoglein 3 are more frequently detected in healthy individuals than in patients with pemphigus vulgaris.
Veldman C; Höhne A; Dieckmann D; Schuler G; Hertl M
J Immunol; 2004 May; 172(10):6468-75. PubMed ID: 15128839
[TBL] [Abstract][Full Text] [Related]
20. Induction of IL-17+ T cell trafficking and development by IFN-gamma: mechanism and pathological relevance in psoriasis.
Kryczek I; Bruce AT; Gudjonsson JE; Johnston A; Aphale A; Vatan L; Szeliga W; Wang Y; Liu Y; Welling TH; Elder JT; Zou W
J Immunol; 2008 Oct; 181(7):4733-41. PubMed ID: 18802076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
